- Citations, last 5 years
- 120
- Works, last 5 years
- 15
- h-index
- 21
- Scientists listed
- 0
- Grants since 2016
- 34
Grants received
2025–2028 · contract · N43
CRISPR-based Assay for Portable Tropical Infection Diagnosis
Dmitriy Zhukov · ChromoLogic (United States) · funded by National Institutes of Health
2025–2026 · research · R43
Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission
Dmitriy V Zhukov · ChromoLogic (United States) · funded by National Institute for Occupational Safety and Health
2025–2030 · cooperative agreement · U01
Validation of a microRNA panel to pre-symptomatically predict the risk of radiation-induced fibrosis
Diana Lin Gage · ChromoLogic (United States) · funded by National Institutes of Health
2024–2025 · contract · N43
SBIR Topic 134: Alternatives to Benzathine Penicillin for Treatment of Syphilis
Jorge Jimenz · ChromoLogic (United States) · funded by National Institutes of Health
2024–2025 · contract · N43
PHASE I AWARD - AN ORGAN-ON-VASCULARNET MODEL FOR IN VITRO EVALUATION OF RADIATION AND DRUG THERAPIES
Claude Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-beta
Joel S Greenberger · ChromoLogic (United States) · funded by National Institutes of Health
2023–2024 · contract · N43
CRISPR-based Tropical Infection Diagnostics
Dmitry Zhukov · ChromoLogic (United States) · funded by National Institutes of Health
2023–2024 · contract · N01
MIDOS: A MICRORNA BIODOSIMETER
Theresa Nguyen · ChromoLogic (United States) · funded by National Institutes of Health
2023–2025 · contract · N01
Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices
Theresa Nguyen · ChromoLogic (United States) · funded by National Institutes of Health
2023–2026 · contract · N01
Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices
Theresa Nguyen · ChromoLogic (United States) · funded by National Institutes of Health
2022–2023 · research · R43
Eye-Path Resubmission
Espoir Kyubwa · ChromoLogic (United States) · funded by National Institutes of Health
2022–2026 · research · R42
NGS based metagenomic screening of ocular infections
Espoir Kyubwa · ChromoLogic (United States) · funded by National Institutes of Health
2022–2027 · research · R42
NGS based metagenomic screening of ocular infections
Espoir Kyubwa · ChromoLogic (United States) · funded by National Institutes of Health
2021–2023 · research · R41
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β
Joel S Greenberger · ChromoLogic (United States) · funded by National Institutes of Health
2021–2024 · contract · N01
Development of second-generation probiotics as radiation mitigators
Claude Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2021–2024 · contract · N44
Mobile Health Point-of-Care Diagnostics for Malaria
Rhoda Price · ChromoLogic (United States) · funded by National Institutes of Health
2021–2023 · contract · N01
Development of second-generation probiotics as radiation mitigators
Claude Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Development of second-generation probiotics as radiation mitigators
Claude Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2021–2025 · contract · N01
Development of second-generation probiotics as radiation mitigators
Claude Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2021–2023 · research · R41
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β
Joel S Greenberger · ChromoLogic (United States) · funded by National Institutes of Health
2021–2028 · research · R42
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β
Joel S Greenberger · ChromoLogic (United States) · funded by National Institutes of Health
2019–2020 · contract · N43
POINT-OF-CARE DIAGNOSTICS FOR MALARIA
Agnes Lukaszewicz · ChromoLogic (United States) · funded by National Institutes of Health
2018–2019 · grant · Standard Grant
SBIR Phase I: A Novel Analytical Tool to Localize the Epileptogenic Zone in Medically-Refractory Epilepsy
Jorge Gonzalez-Martinez · ChromoLogic (United States) · funded by National Science Foundation
2017–2018 · contract · N43
SBIR Topic 359 Phase I: Highly-Efficient Isolation and Fidelity Differentiation of Exosomes (HIFiDE) from Bodily Fluids Kit
Donald Johnson · ChromoLogic (United States) · funded by National Institutes of Health
2017–2022 · contract · N01
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2017–2021 · contract · N01
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2017–2023 · contract · N01
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2017–2020 · contract · N01
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2017–2019 · contract · N01
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health
2014–2021 · research · R44
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
Claude J. Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2014–2021 · research · R44
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
Claude J. Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2014–2024 · research · R44
MicroRNA-based Radiation Biodosimeter (MiRAD) Phase II
Claude J. Rogers · ChromoLogic (United States) · funded by National Institutes of Health
2012–2021 · research · R44
Ocular Flare Meter (OFAM) Development Phase II
Naresh Menon · ChromoLogic (United States) · funded by National Institutes of Health